Iranian Scientists Produce Cell Sheets for Treatment of Diabetic Wounds, Severe Burns

“This knowledge-based company is active in production of multiple cell, tissue and gene therapy products. Recently, two skin products which are tissue cell sheets have entered the country's official pharmaceutical list,” Sara Pousti, a researcher of the knowledge-based company, told ANA.

“These products are used for people who have severe diabetes and their diabetic foot ulcers lead to amputation, or people who have hard jobs and have suffered third degree burns and deep bruises,” she added.

“When these cell sheets are transplanted on the burn area or diabetic foot wounds, they cause complete restoration of the lost tissue and prevent amputation,” Pousti noted, adding that the safety, sterility, identity, effectiveness, degree of purity and performance of the final product of these two products have been approved by experts through various quality control tests.

In a relevant development in January, researchers at a knowledge-based company in Iran had also produced skin repair creams that regenerate skin.

Reza Sahebi, the managing direcor of a knowledge-based company in Iran that produces regenerative skin cream, said that their creams are produced based on plant, human exosomes, algae and medicinal mushrooms.

“The knowledge-based product of this company is healing creams that is categorized in the field of regenerative medicine. These creams are either driven from the cells of the patients themselves or are plant-based," the researcher said.

He said that they produced the skin repair cream based on biological scaffold materials in order to convey the necessary message related to the synthesis of collagen and various growth factors to the deeper layers of the skin. “This cream is useful for healing wounds, eczema and skin rashes and even for things like wrinkles and better skin hydration.”

“This product is now on the way to commercialization. Its clinical trials pahses have been conducted and ISO standards approvals have also been received. By receiving a large-scale production license, this product can enter the market widely by the end of this year,” Sahebi continued.

The managing director of the company further noted that their product can meet the needs of the domestic market, adding, “We are capable of meeting the needs of the market whatever the size of the market is. We have the capability to produce 10,000 to 100,000 data-x-items of each of these products,” he concluded.

4155/v